When the pharmaceutical company Johnson & Johnson reports its quarterly financial results on Tuesday morning, it will mark the company’s first financial report that doesn’t include the results of its consumer health division that separated from the company over the summer.
Wall Street analysts expect Johnson & Johnson to report earnings of $2.52 per share for the third quarter and sales of $21 billion, according to FactSet. Sales were $42.4 billion for the first two quarters of the year, excluding the parts of the business that are now within Kenvue. Of that sum, $27.1 billion was in the company’s pharmaceutical division and $15.3 billion was in its medical device division.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Herkunft: CNBC - 🏆 12. / 72 Weiterlesen »
Herkunft: CNBC - 🏆 12. / 72 Weiterlesen »
Herkunft: MarketWatch - 🏆 3. / 97 Weiterlesen »
Herkunft: Investingcom - 🏆 450. / 53 Weiterlesen »
Herkunft: MarketWatch - 🏆 3. / 97 Weiterlesen »